Skip to content

Public FDA record

Z-1150-2021: Infusion Pump

Recall record Z-1150-2021 for Baxter Healthcare Corporation. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-1150-2021
Company in FDA record
Baxter Healthcare Corporation
FDA record creation date
Feb 25, 2021
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Battery performance issues related to prolonged storage.

Source facts

Action
1. If your facility is currently installing or planning to install new pumps and batteries that are currently in storage, please contact Baxter Technical Assistance at 800 356-3454 (choose option 1) Monday through Friday, between 7:00 am and 7:00 pm Eastern Time, for further instructions. The duration and conditions under which the new batteries have been stored will help determine whether battery damage due to depletion is likely. 2. For facilities currently using Spectrum pumps: If you are not experiencing recurrent battery alerts/alarms, continue using the Spectrum battery modules as indicated. If you are experiencing recurrent battery alerts/alarms, please operate your pumps on AC power and contact Baxter Technical Assistance at 800-356-3454 (choose option 1) Monday through Friday, between 7:00 am and 7:00 pm Eastern Time. 3.Baxter is advising all customers who plan prolonged storage of Spectrum pumps and batteries to ensure the following: Batteries are charged to 2 or 3 bars prior to storage (do not fully charge); Batteries are stored between -10 and +35 degrees C (14 and 95 degrees F); Batteries are removed from the pump and stored independent of the pumps; and Batteries are recharged every six months while in storage. Not following these storage instructions can result in battery damage and/or reduced capacity and life of the battery. 4. The Spectrum Installation & Maintenance Guide/Service Manual, which can be accessed at https://service.baxter.com/tsportal/, describes a Battery Life Test that can be used to test for battery damage due to depletion. This test is recommended as part of routine maintenance. 5. Customers experiencing recurrent battery alerts/alarms should follow the instructions described in step 2 above. Do not attempt to resolve this issue by performing the battery recovery as described in the Technical Service Bulletins below. The battery recovery process is intended to recover a battery locked in a low c
Initiated
2021-01-06
Root cause
Under Investigation by firm
Terminated
2026-05-04
Distribution
Domestic Distribution: ST, AK, AL, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NE, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VA, VT, WA, WI, WV, WY and Puerto Rico. International Distribution: Canada, Barbados, Bermuda, St. Thomas, Guyana, Trinidad and Tobago, Jamaica and Nassau Bahamas.
Recall number
Z-1150-2021
Recall status
Terminated
CDRH record ID
184542
FDA record created
2021-02-25
Recall event number
86788

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗